CCM
CELG

Channing Capital Management’s Celgene Corp CELG Stock Holding History

Channing Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-24,029
Closed -$2.22M – 126
2019
Q2 		$2.22M Sell
24,029
-69,139
-74% -$6.57M 0.1% 99
2019
Q1 		$8.79M Sell
93,168
-20,186
-18% -$1.77M 0.41% 59
2018
Q4 		$7.26M Buy
113,354
+29,315
+35% +$2.16M 0.36% 72
2018
Q3 		$7.52M Buy
+84,039
New +$7.43M 0.27% 79

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Channing Capital Management's CELG Position: Q3 2019 in Review

Channing Capital Management sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 24,029 shares — an estimated $2.22M sold.

Channing Capital Management first reported a position in CELG in Q3 2018 and held it in 4 quarters. The position peaked at $8.79M in Q1 2019. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Channing Capital Management reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Channing Capital Management sold 24,029 Celgene Corp shares in Q3 2019, an estimated $2.22M.
  • Channing Capital Management first reported a position in Celgene Corp in Q3 2018 and held it in 4 quarters.
  • Channing Capital Management's Celgene Corp position peaked at $8.79M in Q1 2019.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Channing Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.